StonvexLoading…
StonvexStonvexStonvexCore line items from MSCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $850.80M | $3.13B | $2.31B | $1.52B |
Operating Income | $456.90M | $1.71B | $1.25B | $802.26M |
Net Income | $406.00M | $1.20B | $917.64M | $303.65M |
EPS (Diluted) | $5.53 | $15.69 | $11.87 | $7.63 |
Total Assets | $5.55B | $5.70B | $5.39B | $5.37B |
Total Liabilities | $8.32B | $8.36B | $7.31B | $6.26B |
Cash & Equivalents | $385.30M | $515.30M | $400.09M | $347.32M |
Free Cash Flow OCF − CapEx | $304.00M | $1.55B | $1.06B | $614.93M |
Shares Outstanding | 72.90M | 73.60M | 75.18M | 77.37M |